Cytauxzoon felis: A Comprehensive Reference on Feline Cytauxzoonosis
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Cytauxzoon felis is an apicomplexan protozoan parasite transmitted by ticks, primarily the lone star tick (Amblyomma americanum), causing the highly fatal disease cytauxzoonosis in domestic cats. Bobcat fever is a common name for this severe illness.
- The disease pathogenesis is characterized by schizonts within macrophages and monocytes, leading to vascular occlusion and tissue necrosis, particularly in vital organs, followed by erythrocyte invasion causing hemolytic anemia. Clinical signs include acute fever, depression, anorexia, and icterus, with rapid progression and high mortality rates exceeding 90% in untreated cats.
- Diagnosis is confirmed by microscopic identification of intraerythrocytic piroplasms or tissue schizonts, but real-time PCR (qPCR) is the gold standard for sensitive and specific DNA detection. Serological assays like IgM ELISA are valuable for epidemiological surveys and identifying subclinical infections.
- Current treatment involves a combination of atovaquone and azithromycin, coupled with aggressive supportive care including fluid therapy and nutritional support, though the prognosis remains guarded to poor.
- Prevention focuses on rigorous tick control measures for domestic cats, such as regular acaricide application and limiting outdoor access in endemic areas, as no commercial vaccine is currently available.
- Cytauxzoon felis is endemic in the south-central and southeastern United States, with expanding geographic distribution, and related Cytauxzoon species have been identified in wild and domestic felids globally, underscoring the need for ongoing surveillance.
Introduction
Cytauxzoon felis is a tick-borne apicomplexan protozoan parasite belonging to the order Piroplasmida and family Theileriidae [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. It is the causative agent of cytauxzoonosis, a highly fatal disease of domestic cats (Felis catus) in the United States, often referred to as "bobcat fever" [<a href="#ref-3">3</a>]. The parasite is characterized by a complex life cycle involving both a mammalian host and an ixodid tick vector [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The disease is marked by rapid onset of severe clinical signs, including fever, depression, anorexia, icterus, and high mortality in domestic cats [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. The bobcat (Lynx rufus) is considered the primary reservoir host, in which infections are typically subclinical [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. This article provides a detailed, publication-grade reference on the biology, epidemiology, pathogenesis, diagnosis, and management of C. felis, with a focus on molecular diagnostics and veterinary clinical relevance.
Taxonomy and Phylogeny
Cytauxzoon felis is classified within the phylum Apicomplexa, class Aconoidasida, order Piroplasmida, and family Theileriidae [<a href="#ref-2">2</a>]. Molecular phylogenetic analyses based on 18S rRNA gene sequences have placed C. felis within a clade that includes other Cytauxzoon species and Theileria species [<a href="#ref-2">2</a>]. The genus Cytauxzoon comprises multiple species infecting wild and domestic felids globally. These include Cytauxzoon europaeus in European wildcats (Felis silvestris) [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>], Cytauxzoon manul in Eurasian lynx (Lynx lynx) and Pallas's cats [<a href="#ref-13">13</a>], Cytauxzoon brasiliensis sp. nov. in little-spotted-cats (Leopardus tigrinus) from Brazil [<a href="#ref-14">14</a>], and Cytauxzoon paradoxurus n. sp. in common palm civets (Paradoxurus hermaphroditus) in Singapore [<a href="#ref-15">15</a>]. In South America, multiple Cytauxzoon species have been identified in wild felids such as ocelots (Leopardus pardalis) and pumas (Puma concolor) [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. The diversity of Cytauxzoon spp. in Brazil and Argentina underscores the complex evolutionary history of this genus [<a href="#ref-17">17</a>].
Life Cycle and Transmission
The life cycle of C. felis involves two main hosts: a mammalian felid host and a tick vector. The primary tick vector in North America is the lone star tick, Amblyomma americanum [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. Transmission occurs when an infected tick feeds on a susceptible felid. The parasite undergoes sexual reproduction in the tick gut, followed by development of sporozoites in the salivary glands [<a href="#ref-5">5</a>]. Inoculation of sporozoites into the mammalian host occurs during tick feeding [<a href="#ref-4">4</a>]. Experimental transmission has been demonstrated by injection of A. americanum salivary glands into domestic cats [<a href="#ref-4">4</a>]. Within the mammalian host, sporozoites invade macrophages and monocytes, where they undergo schizogony, producing large schizonts that distend and eventually rupture the host cells [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. This schizont stage is pathognomonic for cytauxzoonosis. Merozoites released from schizonts then invade erythrocytes, forming intraerythrocytic piroplasms [<a href="#ref-1">1</a>]. The piroplasm stage is infectious to ticks, completing the cycle when a naive tick feeds on an infected cat [<a href="#ref-9">9</a>]. The role of domestic cats as reservoirs for C. felis is debated; while they can develop patent parasitemia, they are generally considered dead-end hosts due to high mortality, though subclinically infected cats may contribute to transmission [<a href="#ref-9">9</a>].
Epidemiology and Geographic Distribution
Cytauxzoon felis is endemic in the south-central, southeastern, and mid-Atlantic United States, with expanding geographic range [<a href="#ref-6">6</a>, <a href="#ref-8">8</a>, <a href="#ref-18">18</a>]. Cases have been reported from states including Oklahoma, Arkansas, Missouri, Texas, Indiana, and others [<a href="#ref-6">6</a>, <a href="#ref-8">8</a>]. The prevalence in bobcats, the primary reservoir, can be high; a study across Oklahoma reported a prevalence of 84.6% in bobcats [<a href="#ref-8">8</a>]. In domestic cats, prevalence varies by region and diagnostic method. A study in south-central USA using qPCR and ELISA found infection rates of 12.5% and 18.8% respectively [<a href="#ref-19">19</a>]. In Iran, a molecular study using real-time PCR detected C. felis in 6.7% of domestic cats [<a href="#ref-20">20</a>]. In northeastern Thailand, molecular detection of vector-borne pathogens including C. felis was reported in cats [<a href="#ref-21">21</a>]. In Europe, C. europaeus has been detected in wildcat populations in Spain, Germany, and Hungary [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>]. A survey in Hungary found C. europaeus in wildcats but not in domestic cats [<a href="#ref-12">12</a>]. In Africa, C. felis has been detected in ticks collected from wildlife in Ghana [<a href="#ref-24">24</a>]. In South America, multiple Cytauxzoon species have been identified in wild felids in Brazil and Argentina [<a href="#ref-14">14</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-25">25</a>]. The parasite has also been detected in captive lions and tigers in zoos in the United States [<a href="#ref-26">26</a>].
Pathogenesis and Clinical Signs
The pathogenesis of cytauxzoonosis is primarily driven by the schizogenous stage of the parasite. Schizonts within macrophages and monocytes cause widespread vascular occlusion and tissue necrosis, particularly in the lungs, liver, spleen, and lymph nodes [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. The release of merozoites and subsequent erythrocyte parasitism leads to hemolytic anemia, though the severity of anemia is often less pronounced than the systemic inflammatory response [<a href="#ref-7">7</a>]. Clinical signs in domestic cats typically develop 5 to 14 days after tick inoculation and include acute onset of fever (often exceeding 40.5 degrees C), depression, anorexia, lethargy, icterus, pale mucous membranes, and splenomegaly [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. Respiratory signs such as tachypnea and dyspnea may occur due to pulmonary edema and vascular damage [<a href="#ref-3">3</a>]. Without treatment, the disease progresses rapidly, with death often occurring within 3 to 5 days of clinical onset [<a href="#ref-6">6</a>]. Mortality rates in untreated domestic cats exceed 90% [<a href="#ref-3">3</a>]. Subclinical infections have been documented in some cats, particularly in endemic areas, suggesting a spectrum of disease severity [<a href="#ref-18">18</a>]. Serum biochemical changes in naturally infected cats include hyperbilirubinemia, elevated liver enzyme activities, and azotemia [<a href="#ref-7">7</a>]. Differential gene expression analysis has revealed distinct host responses in acute versus chronic C. felis infection [<a href="#ref-27">27</a>].
Diagnosis
Diagnosis of cytauxzoonosis relies on a combination of clinical presentation, hematological findings, and laboratory testing. Definitive diagnosis is achieved through detection of the parasite in blood smears or tissue samples.
Microscopic Examination
Examination of Giemsa-stained blood smears can reveal intraerythrocytic piroplasms, which appear as small (1 to 2 micrometers), round to oval, basophilic structures within red blood cells [<a href="#ref-1">1</a>, <a href="#ref-28">28</a>]. The schizont stage can be identified in aspirates or biopsies of lymph nodes, spleen, or liver, appearing as large (10 to 20 micrometers) structures containing numerous merozoites [<a href="#ref-28">28</a>]. However, microscopic examination has limited sensitivity, particularly in subclinical or early infections [<a href="#ref-28">28</a>].
Molecular Diagnostics
Real-time PCR (qPCR) is the gold standard for detection of C. felis DNA, offering high sensitivity and specificity [<a href="#ref-19">19</a>, <a href="#ref-20">20</a>, <a href="#ref-29">29</a>]. Several qPCR assays targeting the 18S rRNA gene have been developed and validated [<a href="#ref-29">29</a>]. A novel real-time PCR approach has been described for simultaneous detection of Cytauxzoon spp. and Hepatozoon spp. in felids [<a href="#ref-29">29</a>]. Molecular detection has been used extensively in epidemiological studies to determine prevalence in wild and domestic felids [<a href="#ref-8">8</a>, <a href="#ref-21">21</a>, <a href="#ref-25">25</a>, <a href="#ref-30">30</a>, <a href="#ref-31">31</a>]. In Romania, apicomplexan haemoparasites including C. felis were detected in domestic cats using PCR [<a href="#ref-30">30</a>]. In Brazil, piroplasmid infection was not associated with clinicopathological abnormalities in cats, highlighting the value of molecular screening [<a href="#ref-31">31</a>].
Serological Assays
Enzyme-linked immunosorbent assays (ELISAs) have been developed for detection of antibodies against C. felis. An IgM ELISA has been described for serodiagnosis of acute cytauxzoonosis [<a href="#ref-32">32</a>]. A commercial ELISA kit has been utilized for detection of C. felis antibodies in domestic cats [<a href="#ref-19">19</a>]. Serological testing is useful for epidemiological surveys and for identifying subclinical infections [<a href="#ref-19">19</a>, <a href="#ref-32">32</a>].
Diagnostic Algorithm
The following Mermaid diagram outlines a diagnostic decision tree for suspected cytauxzoonosis.
flowchart TD
A["Suspected Cytauxzoonosis<br>Fever, depression, icterus<br>Tick exposure history"] --> B{"Blood smear examination"}
B -->|"Intraerythrocytic piroplasms<br>or schizonts detected"| C["Presumptive positive<br>Initiate treatment"]
B -->|"No piroplasms detected"| D{"Real-time PCR<br>for C. felis DNA"}
D -->|"Positive"| C
D -->|"Negative"| E{"Serology<br>IgM ELISA"}
E -->|"Positive"| F["Recent or acute infection<br>Consider treatment"]
E -->|"Negative"| G["Cytauxzoonosis unlikely<br>Consider other diagnoses"]
C --> H["Monitor clinical signs<br>Repeat blood smear"]Treatment and Management
Treatment of cytauxzoonosis is challenging and requires aggressive supportive care. The current standard of care involves a combination of antiprotozoal drugs and supportive therapy. Atovaquone (15 mg/kg orally every 8 hours) combined with azithromycin (10 mg/kg orally every 24 hours) has been shown to improve survival rates compared to historical treatments [<a href="#ref-3">3</a>]. Supportive care includes intravenous fluid therapy, nutritional support, and management of complications such as anemia, hypoxia, and disseminated intravascular coagulation [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>]. Despite treatment, mortality remains high, particularly in cats presenting with severe clinical signs [<a href="#ref-6">6</a>]. A novel vaccine strategy has been explored in experimental settings, though no commercial vaccine is currently available [<a href="#ref-33">33</a>]. An in vitro culture system for C. felis has been established, which may facilitate future drug and vaccine development [<a href="#ref-34">34</a>].
Prevention and Control
Prevention of cytauxzoonosis relies on tick control measures in domestic cats. Regular application of acaricides is recommended to reduce exposure to A. americanum and other tick vectors [<a href="#ref-1">1</a>]. Limiting outdoor access in endemic areas can also decrease risk [<a href="#ref-3">3</a>]. There is no approved vaccine for C. felis, though experimental vaccine approaches have shown promise [<a href="#ref-33">33</a>]. The role of bobcats as reservoir hosts complicates control efforts, as wildlife populations maintain the parasite in the environment [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>].
Public Health and One Health Considerations
Cytauxzoon felis is not considered a zoonotic pathogen. However, the parasite is of significant veterinary and ecological importance. The expanding geographic range of C. felis in North America and the emergence of novel Cytauxzoon species in Europe, Asia, and South America highlight the need for continued surveillance [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. The detection of C. felis in ticks from wildlife in Ghana suggests a broader distribution than previously recognized [<a href="#ref-24">24</a>]. Understanding the ecology of tick vectors and reservoir hosts is critical for predicting and managing disease emergence [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-35">35</a>]. Ticks collected from domestic cats across the USA have been shown to harbor C. felis, underscoring the importance of tick surveillance in companion animals [<a href="#ref-35">35</a>].
Frequently Asked Questions
What is Cytauxzoon felis?
Cytauxzoon felis is a tick-borne protozoan parasite that causes cytauxzoonosis, a severe and often fatal disease in domestic cats [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].
How is Cytauxzoon felis transmitted?
Transmission occurs through the bite of an infected tick, primarily Amblyomma americanum in North America [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>].
What are the clinical signs of cytauxzoonosis?
Clinical signs include acute fever, depression, anorexia, icterus, pale mucous membranes, and splenomegaly, often progressing rapidly to death [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>].
How is cytauxzoonosis diagnosed?
Diagnosis is confirmed by detection of intraerythrocytic piroplasms on blood smear, schizonts in tissue aspirates, or by real-time PCR detection of C. felis DNA [<a href="#ref-19">19</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>].
What is the treatment for cytauxzoonosis?
Treatment involves atovaquone combined with azithromycin, along with aggressive supportive care [<a href="#ref-3">3</a>].
Can domestic cats be reservoirs for Cytauxzoon felis?
Domestic cats are generally considered dead-end hosts, but subclinical infections may allow them to serve as reservoirs in some contexts [<a href="#ref-9">9</a>].
Is Cytauxzoon felis found outside the United States?
Yes, Cytauxzoon species have been detected in Europe, Asia, South America, and Africa [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-20">20</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>, <a href="#ref-30">30</a>].
What is the prognosis for a cat with cytauxzoonosis?
The prognosis is guarded to poor, with high mortality even with treatment [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>].
How can cytauxzoonosis be prevented?
Prevention relies on tick control using acaricides and limiting outdoor exposure in endemic areas [<a href="#ref-1">1</a>].
Is there a vaccine for Cytauxzoon felis?
No commercial vaccine is available, though experimental vaccine strategies are under investigation [<a href="#ref-33">33</a>].